This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version    RSS    Subscribe    Unsubscribe    Archive    Media Kit May. 10, 2012

Home   About AST   Education   Meetings & Events   Public Policy   Contact Us  


Bio X Cell

We are a cell culture service company located in West Lebanon, NH.

 



 SOCIETY NEWS


Do you have open positions?
AST    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Want to increase your visibility and recruiting power?
Plan now to participate in the 1st annual AST Job Fair @ ATC

Take this opportunity to meet individually with job seekers interested in learning more about open positions. Schedule interviews now to take place during the 2012 American Transplant Congress in Boston, MA from June 2-6. Simply post your job to the AST Career Center and register to participate in the job fair.

To learn more, visit www.a-s-t.org/jobfair.




Please join us at the ATC!
AST    Share    Share on FacebookTwitterShare on LinkedinE-mail article
See the AST listing of events at ATC June 2-6, 2012.

AST board of directors elections
AST    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Voting is now open for the American Society of Transplantation's board of directors. Eligible AST members may vote by proxy in the new online election format. Vacant seats on the board include president-elect, secretary-treasurer and four councilors-at-large.

All votes must be cast by Monday, June 4, 2012 at 5 p.m. EDT.

Learn more and vote.


Pfizer Advancing Research in Transplantation Science (ARTS) Grant Program
Pfizer is proud to support the ARTS Grants Program - a competitive, independent, peer-reviewed program for investigators in the United States.*

To apply for research grants and learn more about the program, the PfizerARTS website (www.PfizerARTS.com) will open for submissions on March 1, 2012 and the deadline for submissions is April 30, 2012 at midnight.

*Program open to US investigators only.


Join the conversation with CenterSpan
AST    Share    Share on FacebookTwitterShare on LinkedinE-mail article
CenterSpan is the listserv where your colleagues go to discuss transplantation and immunology topics. It's an easy way to get your peers' thoughts on your latest challenge and to contribute your expertise by weighing in on someone else's question. By signing up for the CenterSpan listserv, you can choose the specific topics you are interested in and receive each email either individually or in digest form. Don't be left out of the conversation! Sign up at www.asts.org/ListServSubscribe.aspx today.

Transplant Services at Home

• Home Infusion
• Specialty Infusion
• Clinical Pharmacy
• Infusion Nursing
• PO Medications
• Ongoing Monitoring and Education
• Benefit Verification
• Patient Support 24/7
• Community Involvement

For comprehensive services, call 877.974.4844 or 877.974.4845.


 TRANSPLANT NEWS


Hepatitis E virus infection among solid organ transplant recipients, the Netherlands
CDC    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The CDC screened 1,200 living heart, lung, liver and kidney transplant recipients for hepatitis E virus infection by reverse transcription PCR. In 12 (1 percent) patients, hepatitis E virus infection was identified; in 11 patients, chronic infection developed. This immunocompromised population is at risk for hepatitis E virus infection. More

New surgical technique for removing inoperable tumors of the abdomen
American Journal of Transplantation    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A case report published in the journal American Journal of Transplantation presents a novel surgical technique that enables surgeons to remove tumors that are unresectable by the usual surgical techniques. Abdominal tumors involving both roots of the celiac and superior mesenteric artery (SMA) are deemed unresectable by conventional surgical methods, as removal would cause necrosis of the organs that are supplied by those blood vessels. More


Choose Quality. Choose Champion

Champion patient recliners work harder and last longer. Heavy duty steel frames and mechanisms stand up to the most rigorous use. Beautiful styling and a wide palette of colors and patterns make it feel right at home in any healthcare environment. MORE
Iso-Tex Diagnostics, Inc.

• We are an FDA licensed manufacturer.
• We label peptides, monoclonal antibodies, reagents, chemical   and proteins for cancer treatments.
• Our above products can be labeled with radioisotopes such as   I-125, I-131, P32, Tc99m, Y90 and AC-225.
• We have a multicurie isotope license and an animal facility.
Designs for Vision
The purpose of Surgical Telescopes is to enhance or magnify an image to insure the highest quality results in surgical procedures. We take our responsibility to surgeons and their patients seriously so all of our Surgical Telescopes provide the TRUE magnification that is expected. More info


Compassionate use of Pluristem's PLX cells saves the life of a child after bone marrow transplantation failure
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Pluristem Therapeutics, Inc. recently announced that a 7-year-old girl suffering from an aplastic bone marrow whose condition was rapidly deteriorating is now experiencing a reversal of her condition with a significant increase in her red cells, white cells and platelets following the intramuscular injection of the company's PLacental eXpanded (PLX) cells. Aplastic bone marrow is a disease where the patient has no blood-forming hematopoietic stem cells in the bone marrow. More


Custodiol® HTK
is indicated for perfusion and flushing of donor kidneys, liver, pancreas and heart prior to removal from the donor or immediately after removal from the donor. The solution is left in the organ vasculature during hypothermic storage and transportation (not for continuous perfusion) to the recipient. Visit Essential Pharmaceuticals at Booth # 1101 to pick up the latest studies. MORE
CryoLife
SynerGraft is CryoLife's patented decellularization technology that serves as the foundation for the next generation of implantable biological tissues. MORE


Making organ donation a thing of the past — the British lab growing human spare parts
The Mail Online    Share    Share on FacebookTwitterShare on LinkedinE-mail article
"This is a nose we're growing for a patient next month," Professor Alexander Seifalian says matter-of-factly, plucking a Petri dish from the bench beside him. Inside is an utterly lifelike appendage, swimming in red goo. Alongside it is another dish containing an ear. Regenerative medicine is now moving on from replacing heart valves and rebuilding faces to potentially curing blindness and accelerating the study of some of the most debilitating diseases. The U.K. is at the forefront of this research, with work on a £54 million (US $87 million) MRC Center for Regenerative Medicine in Edinburgh completed earlier this year. More

2 Cell Transplantation studies impact dental stem cell research for therapeutic purposes
Science Codex    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Two studies appearing in a recent issue of Cell Transplantation (20:11-12), now available on-line at http://www.ingentaconnect.com/content/cog/ct/, evaluate stem cells derived from dental tissues for characteristics that may make them therapeutically useful and appropriate for transplantation purposes. More
 


AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Courtney Hodges, Content Editor, 972.402.2604   
Contribute news


This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues
May 4, 2012
April 26, 2012
April 19, 2012
April 12, 2012






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063